ArticlePharmacoEconomics2015

Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland.

Florian S Gutzwiller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.